More people with relapsing MS have started VUMERITY® (diroximel fumarate) than any other brand-name pill in the US since December 2020.* Could it be right for you? Take a look at the video below to find out more.
Meet Nichole and Giseli, two of our ambassadors, and hear how they decided on VUMERITY.
*Based on the number of new MS prescriptions for the months December 2020 through September 2021 per IQVIA NPA New to Brand, Patient Insights® monthly NBRx.
“Every day I have a choice. I can say, ‘Why me?’ or I can say, ‘Why not me?’ I choose to say, ‘Why not me? ’”